Abstract

In cancer, aberrant growth factor receptor signaling reprograms cellular metabolism and global gene transcription to drive aggressive growth, but the underlying mechanisms are not well-understood. Here we show that in the highly lethal brain tumor glioblastoma (GBM), mTOR complex 2 (mTORC2), a critical core component of the growth factor signaling system, couples acetyl-CoA production with nuclear translocation of histone-modifying enzymes including pyruvate dehydrogenase and class IIa histone deacetylases to globally alter histone acetylation. Integrated analyses in orthotopic mouse models and in clinical GBM samples reveal that mTORC2 controls iron metabolisms via histone H3 acetylation of the iron-related gene promoter, promoting tumor cell survival. These results nominate mTORC2 as a critical epigenetic regulator of iron metabolism in cancer.

Highlights

  • In cancer, aberrant growth factor receptor signaling reprograms cellular metabolism and global gene transcription to drive aggressive growth, but the underlying mechanisms are not well-understood

  • Having shown that histone acetylation is dynamically controlled by mTOR complex 2 (mTORC2) through metabolic reprogramming, we examined its epigenetic effect on the expression of tumorpromoting genes because histone acetylation is generally considered to relax the chromatin configuration and facilitate the gene transcription [23, 24]

  • We have found that mTORC2 promotes GBM growth by altering iron metabolism, and we demonstrate that this activity is mediated by promoter histone modification

Read more

Summary

Results

To examine the histone acetylation status in human GBM, we performed quantitative immunohistochemical analyses of EGFR/mTORC2 signaling, glycolytic enzyme lactate dehydrogenase A (LDHA) expression, and acetylation of histone H3 transferase; HDAC, histone deacetylase; TSA, tricostatin A; TSS, transcription start site; TFR, transferrin receptor; FTL, ferritin light chain; FTH1, ferritin heavy chain 1; FAC, ferric ammonium citrate; GAPDH, glyceraldehyde3-phosphate dehydrogenase

Epigenetic regulation of iron metabolism in glioblastoma
Discussion
Cell culture and human samples
Antibodies and reagents
Metabolome analysis
Western blot and immunoprecipitation
Quantification of total intracellular iron by atomic absorption spectrometry
Quantitative measurement of soluble iron in the media
Animal studies
Statistical analysis

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.